Condition: Intraabdominal Hypertension · Abdominal Compartment Syndrome · Acute Kidney Injury · Sponsor: Potrero Medical
The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.
This description comes directly from the study's public registry record.
Bev Ann Blackwell · 256-679-5422 · bblackwell@potreromed.com
Ariane Marcus · 888-635-7280 · amarcus@potreromed.com
Always discuss trial participation with your own doctor first.
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Active Not Recruiting |
| San Francisco VA Medical Center | San Francisco, California, United States | Terminated |
| George Washington University Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| Cleveland Clinic Florida | Weston, Florida, United States | Recruiting |
| Jewish Hospital / University of Louisville | Louisville, Kentucky, United States | Recruiting |
| Mission Health Hospital | Asheville, North Carolina, United States | Recruiting |
| Duke University Hospital | Durham, North Carolina, United States | Recruiting |
| Wake Forest Baptist Medical Center | Winston-Salem, North Carolina, United States | Active Not Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04669548